Promoter hypermethylation of progesterone receptor isoform B (PR-B) in adenomyosis and its rectification by a histone deacetylase inhibitor and a demethylation agent

Reproductive Sciences

Volumn 17, Issue 11, 2010, Pages 995-1005

  Nie, Jichan ^a   Liu, Xishi ^a   Guo, Sun Wei ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

adenomyosis; demethylation; histone deacetylase inhibitor; methylation; progesterone receptor isoform B

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; PROGESTERONE RECEPTOR B; TRICHOSTATIN A;

ADENOMYOSIS; ADULT; ARTICLE; CELL ASSAY; CELL CULTURE; CELL CYCLE PROGRESSION; CELL ISOLATION; CELL VIABILITY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEMETHYLATION; DNA METHYLATION; DOSE RESPONSE; ENDOMETRIAL STROMAL TUMOR; ENDOMETRIOSIS; ENDOMETRIUM; ENDOMETRIUM CELL; EPIGENETICS; ERYTHROCYTE; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; GENETIC DISORDER; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; METHYLATION; MYOMA; OVARY CYST; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA CELL; WESTERN BLOTTING;

AZACITIDINE; CELLS, CULTURED; DNA MODIFICATION METHYLASES; ENDOMETRIOSIS; ENDOMETRIUM; ENZYME INHIBITORS; FEMALE; HISTONE DEACETYLASE INHIBITORS; HUMANS; HYDROXAMIC ACIDS; METHYLATION; PROMOTER REGIONS, GENETIC; RECEPTORS, PROGESTERONE; STROMAL CELLS;

EID: 77957976878     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719110377118     Document Type: Article

References (46)

1. Bergeron C., Amant F., Ferenczy A. Pathology and physiopathology of adenomyosis. Best Pract Res Clin Obstet Gynaecol. 2006 ; 20 (4). 511-521.
2. Farquhar C., Brosens I. Medical and surgical management of adenomyosis. Best Pract Res Clin Obstet Gynaecol. 2006 ; 20 (4). 603-616.
3. Kitawaki J. Adenomyosis: the pathophysiology of an oestrogen-dependent disease. Best Pract Res Clin Obstet Gynaecol. 2006 ; 20 (4). 493-502.
4. Grow DR, Filer RB Treatment of adenomyosis with long-term GnRH analogues: a case report. Obstet Gynecol. 1991 ; 78 (3 pt 2). 538-539.
5. Cho S., Nam A., Kim H., et al. Clinical effects of the levonorgestrelreleasing intrauterine device in patients with adenomyosis. Am J Obstet Gynecol. 2008 ; 198 (4). 373.e1-373.e7.
6. Ota H., Igarashi S., Hatazawa J., Tanaka T. Is adenomyosis an immune disease ? Hum Reprod Update. 1998 ; 4 (4). 360-367.
7. Maia H. Jr, Maltez A., Studart E., Athayde C., Coutinho EM Effect of menstrual cycle and hormonal treatment on ki-67 and bcl-2 expression and adenomyosis. Gynecol Endocrinol. 2005 ; 20 (3). 127-131.
8. Kunz G., Beil D., Huppert P., Noe M., Kissler S., Leyendecker G. Adenomyosis in endometriosis-prevalence and impact on fertility. Evidence from magnetic resonance imaging. Hum Reprod. 2005 ; 20 (8). 2309-2316.
9. Kunz G., Herbertz M., Beil D., Huppert P., Leyendecker G. Adenomyosis as a disorder of the early and late human reproductive period. Reprod Biomed Online. 2007 ; 15 (6). 681-685.
10. Wu MY, Ho HN The role of cytokines in endometriosis. Am J Reprod Immunol. 2003 ; 49 (5). 285-296.
11. Ulukus M., Ulukus EC, Tavmergen Goker EN, Tavmergen E., Zheng W., Arici A. Expression of interleukin-8 and monocyte chemotactic protein 1 in women with endometriosis. Fertil Steril. 2009 ; 91 (3). 687-693.
12. Ota H., Igarashi S., Sasaki M., Tanaka T. Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis. Hum Reprod. 2001 ; 16 (3). 561-566. (Pubitemid 32218810)
13. Ota H., Igarashi S., Hatazawa J., Tanaka T. Immunohistochemical assessment of superoxide dismutase expression in the endometrium in endometriosis and adenomyosis. Fertil Steril. 1999 ; 72 (1). 129-134.
14. Ota H., Igarashi S., Hatazawa J., Tanaka T. Endothelial nitric oxide synthase in the endometrium during the menstrual cycle in patients with endometriosis and adenomyosis. Fertil Steril. 1998 ; 69 (2). 303-308.
15. Ota H., Igarashi S., Kato N., Tanaka T. Aberrant expression of glutathione peroxidase in eutopic and ectopic endometrium in endometriosis and adenomyosis. Fertil Steril. 2000 ; 74 (2). 313-318.
16. Ota H., Igarashi S., Tanaka T. Xanthine oxidase in eutopic and ectopic endometrium in endometriosis and adenomyosis. Fertil Steril. 2001 ; 75 (4). 785-790. (Pubitemid 32273516)
17. Bulun SE, Cheng YH, Yin P., et al. Progesterone resistance in endometriosis: link to failure to metabolize estradiol. Mol Cell Endocrinol. 2006 ; 248 (1-2). 94-103.
18. Guo SW Nuclear factor-kappab (NF-kappaB): an unsuspected major culprit in the pathogenesis of endometriosis that is still at large ? Gynecol Obstet Invest. 2007 ; 63 (2). 71-97.
19. Hardy DB, Janowski BA, Corey DR, Mendelson CR Progesterone receptor plays a major antiinflammatory role in human myometrial cells by antagonism of nuclear factor-kappaB activation of cyclooxygenase 2 expression. Mol Endocrinol. 2006 ; 20 (11). 2724-2733.
20. Kalkhoven E., Wissink S., van der Saag PT, van der Burg B. Negative interaction between the RelA(p65) subunit of NF-kappaB and the progesterone receptor. J Biol Chem. 1996 ; 271 (11). 6217-6224.
21. Yamamoto K., Arakawa T., Ueda N., Yamamoto S. Transcriptional roles of nuclear factor kappa B and nuclear factor-interleukin-6 in the tumor necrosis factor alpha-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells. J Biol Chem. 1995 ; 270 (52). 31315-31320.
22. Nie J., Lu Y., Liu X., Guo SW. Immunoreactivity of progesterone receptor isoform B, nuclear factor kappaB, and IkappaBalpha in adenomyosis. Fertil Steril. 2009 ; 92 (3). 886-889.
23. Wu Y., Strawn E., Basir Z., Halverson G., Guo SW Promoter hypermethylation of progesterone receptor isoform B (PR-B) in endometriosis. Epigenetics. 2006 ; 1 (2). 106-111.
24. Ryan IP, Schriock ED, Taylor RN Isolation, characterization, and comparison of human endometrial and endometriosis cells in vitro. J Clin Endocrinol Metab. 1994 ; 78 (3). 642-649.
25. Rossi MJ, Chegini N., Masterson BJ Presence of epidermal growth factor, platelet-derived growth factor, and their receptors in human myometrial tissue and smooth muscle cells: their action in smooth muscle cells in vitro. Endocrinology. 1992 ; 130 (3). 1716-1727.
26. Hirota Y., Osuga Y., Hirata T., et al. Possible involvement of thrombin/protease-activated receptor 1 system in the pathogenesis of endometriosis. J Clin Endocrinol Metab. 2005 ; 90 (6). 3673-3679.
27. Liu Y., Peterson DA, Kimura H., Schubert D. Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction. J Neurochem. 1997 ; 69 (2). 581-593.
28. Serafim TL, Oliveira PJ, Sardao VA, Perkins E., Parke D., Holy J. Different concentrations of berberine result in distinct cellular localization patterns and cell cycle effects in a melanoma cell line. Cancer Chemother Pharmacol. 2008 ; 61 (6). 1007-1018.
29. Sakaguchi H., Fujimoto J., Hong BL, Nakagawa Y., Tamaya T. Drastic decrease of progesterone receptor form B but not A mRNA reflects poor patient prognosis in endometrial cancers. Gynecol Oncol. 2004 ; 93 (2). 394-399.
30. Sasaki M., Dharia A., Oh BR, Tanaka Y., Fujimoto S., Dahiya R. Progesterone receptor B gene inactivation and CpG hypermethylation in human uterine endometrial cancer. Cancer Res. 2001 ; 61 (1). 97-102.
31. Tukey JW Exploratory Data Analysis. Reading, MA: Addison-Wesley ; 1977.
32. Inhaka R., Gentleman RR R: a language for data analysis and graphics. J Comput Graph Stat. 1996 ; 5 (3). 1923-1927.
33. Matalliotakis IM, Kourtis AI, Panidis DK Adenomyosis. Obstet Gynecol Clin North Am. 2003 ; 30 (1). 63-82, viii.
34. Devlieger R., D'Hooghe T., Timmerman D. Uterine adenomyosis in the infertility clinic. Hum Reprod Update. 2003 ; 9 (2). 139-147.
35. Peric H., Fraser IS The symptomatology of adenomyosis. Best Pract Res Clin Obstet Gynaecol. 2006 ; 20 (4). 547-555.
36. Guo SW Epigenetics of endometriosis. Mol Hum Reprod. 2009 ; 15 (10). 587-607.
37. Wen DX, Xu YF, Mais DE, Goldman ME, McDonnell DP. The A and B isoforms of the human progesterone receptor operate through distinct signaling pathways within target cells. Mol Cell Biol. 1994 ; 14 (12). 8356-8364.
38. Robertson KD, Wolffe AP DNA methylation in health and disease. Nat Rev Genet. 2000 ; 1 (1). 11-19.
39. Liu X., Guo SW A pilot study on the off-label use of valproic acid to treat adenomyosis. Fertil Steril. 2008 ; 89 (1). 246-250.
40. Matsuoka H., Fujimura T., Mori H., Aramori I., Mutoh S. Mechanism of HDAC inhibitor FR235222-mediated IL-2 transcriptional repression in Jurkat cells. Int Immunopharmacol. 2007 ; 7 (11). 1422-1432.
41. Yang AS, Estecio MR, Garcia-Manero G., Kantarjian HM, Issa JP Comment on ''Chromosomal instability and tumors promoted by DNA hypomethylation'' and ''Induction of tumors in nice by genomic hypomethylation.''. Science. 2003 ; 302 (5648). 1153 ;author reply 1153.
42. Lubbert M., Wijermans P., Kunzmann R., et al. Cytogenetic responses in high-risk myelodysplastic syndrome following low-dose treatment with the DNA methylation inhibitor 5-aza-2'-deoxycytidine. Br J Haematol. 2001 ; 114 (2). 349-357.
43. Garcia-Manero M., Santana GT, Alcazar JL Relationship between microvascular density and expression of vascular endothelial growth factor in patients with ovarian endometriosis. J Womens Health (Larchmt). 2008 ; 17 (5). 777-782.
44. Wu Y., Starzinsky-Powitz A., Guo SW Constitutive and TNFα- stimulated activation of nuclear factor κB (NF-κB) in immortalized endometriotic cells and their suppression by trichostatin A (TSA). Gynecol Obstet Invest. 2010 ; 70 (1). 23-33.
45. Gonzalez-Ramos R., Donnez J., Defrere S., et al. Nuclear factor-kappa B is constitutively activated in peritoneal endometriosis. Mol Hum Reprod. 2007 ; 13 (7). 503-509.
46. Liu XS, Yuan L., Guo SW Vaproic acid as a therapy for adenomyosis: a comparative case series. Reprod Sci. IN PRESS.